Patent Assignment
Reel/Frame 049775/0631
Assignment of Assignor's Interest
Recorded: 2019-07-17
Pages: 3
Assignor
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Executed: 2019-05-07
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Axl Kinase Inhibitors and Use of the Same
Patent:
11,013,741 →
Application:
16/376,452 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 17, 2019
From: SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; FLYNN, PAUL; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049775/0391 →
Assignment of Assignor's Interest
Jul 17, 2019
From: TOMIMATSU, NOZOMI; FUJIMURA, KEN; UMEHARA, HIROKI; NONOYAMA, AKIHITO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 049775/0543 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0424 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0684 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →